Literature DB >> 19435613

Computing with evidence Part I: A drug-mechanism evidence taxonomy oriented toward confidence assignment.

Richard Boyce1, Carol Collins, John Horn, Ira Kalet.   

Abstract

We present a new evidence taxonomy that, when combined with a set of inclusion criteria, enable drug experts to specify what their confidence in a drug mechanism assertion would be if it were supported by a specific set of evidence. We discuss our experience applying the taxonomy to representing drug-mechanism evidence for 16 active pharmaceutical ingredients including six members of the HMG-CoA-reductase inhibitor family (statins). All evidence was collected and entered into the Drug-Interaction Knowledge Base (DIKB); a system that can provide customized views of a body of drug-mechanism knowledge to users who do not agree about the inferential value of particular evidence types. We provide specific examples of how the DIKB's evidence model can flag when a particular use of evidence should be re-evaluated because its related conjectures are no longer valid. We also present the algorithm that the DIKB uses to identify patterns of evidence support that are indicative of fallacious reasoning by the evidence-base curators.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19435613      PMCID: PMC2783801          DOI: 10.1016/j.jbi.2009.05.001

Source DB:  PubMed          Journal:  J Biomed Inform        ISSN: 1532-0464            Impact factor:   6.317


  32 in total

Review 1.  Drug interactions and the statins.

Authors:  R J Herman
Journal:  CMAJ       Date:  1999-11-16       Impact factor: 8.262

2.  Implementing a commercial rule base as a medication order safety net.

Authors:  Richard M Reichley; Terry L Seaton; Ervina Resetar; Scott T Micek; Karen L Scott; Victoria J Fraser; W Claiborne Dunagan; Thomas C Bailey
Journal:  J Am Med Inform Assoc       Date:  2005-03-31       Impact factor: 4.497

3.  Clinical decision support and electronic prescribing systems: a time for responsible thought and action.

Authors:  Randolph A Miller; Reed M Gardner; Kevin B Johnson; George Hripcsak
Journal:  J Am Med Inform Assoc       Date:  2005-05-19       Impact factor: 4.497

4.  Overriding of drug safety alerts in computerized physician order entry.

Authors:  Heleen van der Sijs; Jos Aarts; Arnold Vulto; Marc Berg
Journal:  J Am Med Inform Assoc       Date:  2005-12-15       Impact factor: 4.497

5.  Effect of CYP3A5*3 genotype on the pharmacokinetics and pharmacodynamics of alprazolam in healthy subjects.

Authors:  Ji-Young Park; Kyoung-Ah Kim; Pil-Whan Park; Ock-Je Lee; Dong-Kyun Kang; Ji-Hong Shon; Kwang-Hyun Liu; Jae-Gook Shin
Journal:  Clin Pharmacol Ther       Date:  2006-06       Impact factor: 6.875

6.  Qualitative pharmacokinetic modeling of drugs.

Authors:  Richard Boyce; Carol Collins; John Horn; Ira J Kalet
Journal:  AMIA Annu Symp Proc       Date:  2005

7.  Modeling drug mechanism knowledge using evidence and truth maintenance.

Authors:  Richard D Boyce; Carol Collins; John Horn; Ira Kalet
Journal:  IEEE Trans Inf Technol Biomed       Date:  2007-07

8.  Performance of community pharmacy drug interaction software.

Authors:  T K Hazlet; T A Lee; P D Hansten; J R Horn
Journal:  J Am Pharm Assoc (Wash)       Date:  2001 Mar-Apr

9.  Lactonization is the critical first step in the disposition of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor atorvastatin.

Authors:  W Jacobsen; B Kuhn; A Soldner; G Kirchner; K F Sewing; P A Kollman; L Z Benet; U Christians
Journal:  Drug Metab Dispos       Date:  2000-11       Impact factor: 3.922

10.  The Gene Ontology (GO) project in 2006.

Authors: 
Journal:  Nucleic Acids Res       Date:  2006-01-01       Impact factor: 16.971

View more
  14 in total

1.  Deriving rules and assertions from pharmacogenomics knowledge resources in support of patient drug metabolism efficacy predictions.

Authors:  Casey Lynnette Overby; Emily Beth Devine; Peter Tarczy-Hornoch; Ira J Kalet
Journal:  J Am Med Inform Assoc       Date:  2012-04-26       Impact factor: 4.497

2.  Automatically classifying the evidence type of drug-drug interaction research papers as a step toward computer supported evidence curation.

Authors:  Linh Hoang; Richard D Boyce; Nigel Bosch; Britney Stottlemyer; Mathias Brochhausen; Jodi Schneider
Journal:  AMIA Annu Symp Proc       Date:  2021-01-25

Review 3.  Informatics confronts drug-drug interactions.

Authors:  Bethany Percha; Russ B Altman
Journal:  Trends Pharmacol Sci       Date:  2013-02-13       Impact factor: 14.819

4.  Towards a foundational representation of potential drug-drug interaction knowledge.

Authors:  Mathias Brochhausen; Jodi Schneider; Daniel Malone; Philip E Empey; William R Hogan; Richard D Boyce
Journal:  CEUR Workshop Proc       Date:  2014-10

5.  Computing with evidence Part II: An evidential approach to predicting metabolic drug-drug interactions.

Authors:  Richard Boyce; Carol Collins; John Horn; Ira Kalet
Journal:  J Biomed Inform       Date:  2009-06-16       Impact factor: 6.317

6.  Personalized medicine: challenges and opportunities for translational bioinformatics.

Authors:  Casey Lynnette Overby; Peter Tarczy-Hornoch
Journal:  Per Med       Date:  2013-07-01       Impact factor: 2.512

Review 7.  Translational Knowledge Discovery Between Drug Interactions and Pharmacogenetics.

Authors:  Heng-Yi Wu; Aditi Shendre; Shijun Zhang; Pengyue Zhang; Lei Wang; Desta Zeruesenay; Luis M Rocha; Hagit Shatkay; Sara K Quinney; Xia Ning; Lang Li
Journal:  Clin Pharmacol Ther       Date:  2020-02-03       Impact factor: 6.875

8.  Drug-drug interaction discovery and demystification using Semantic Web technologies.

Authors:  Adeeb Noor; Abdullah Assiri; Serkan Ayvaz; Connor Clark; Michel Dumontier
Journal:  J Am Med Inform Assoc       Date:  2017-05-01       Impact factor: 4.497

9.  Dynamic enhancement of drug product labels to support drug safety, efficacy, and effectiveness.

Authors:  Richard D Boyce; John R Horn; Oktie Hassanzadeh; Anita de Waard; Jodi Schneider; Joanne S Luciano; Majid Rastegar-Mojarad; Maria Liakata
Journal:  J Biomed Semantics       Date:  2013-01-26

10.  Feasibility of incorporating genomic knowledge into electronic medical records for pharmacogenomic clinical decision support.

Authors:  Casey Lynnette Overby; Peter Tarczy-Hornoch; James I Hoath; Ira J Kalet; David L Veenstra
Journal:  BMC Bioinformatics       Date:  2010-10-28       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.